Catalent Expands OneBio Suite for Integrated Development, Manufacturing and Supply Across Biologic Modalities - Marketscreener.com
GU5 Stock | EUR 2.12 0.02 0.93% |
Roughly 61% of Guangzhou Baiyunshan's investor base is looking to short. The analysis of current outlook of investing in Guangzhou Baiyunshan Pharmaceutical suggests that many traders are alarmed regarding Guangzhou Baiyunshan's prospects. The current market sentiment, together with Guangzhou Baiyunshan's historical and current headlines, can help investors time the market. In addition, many technical investors use Guangzhou Baiyunshan stock news signals to limit their universe of possible portfolio assets.
Guangzhou Baiyunshan stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Guangzhou daily returns and investor perception about the current price of Guangzhou Baiyunshan Pharmaceutical as well as its diversification or hedging effects on your existing portfolios.
Guangzhou |
Catalent Expands OneBio Suite for Integrated Development, Manufacturing and Supply Across Biologic Modalities Marketscreener.com
Read at news.google.com
Guangzhou Baiyunshan Fundamental Analysis
We analyze Guangzhou Baiyunshan's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guangzhou Baiyunshan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guangzhou Baiyunshan based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
Guangzhou Baiyunshan is rated below average in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Guangzhou Baiyunshan Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Guangzhou Baiyunshan stock to make a market-neutral strategy. Peer analysis of Guangzhou Baiyunshan could also be used in its relative valuation, which is a method of valuing Guangzhou Baiyunshan by comparing valuation metrics with similar companies.
Peers
Guangzhou Baiyunshan Related Equities
LDZU | ASPEN PHARUNADR | 4.68 | ||||
TSUA | Tsumura | 0.00 | ||||
CJH | CanSino Biologics | 0.55 | ||||
TKDA | Takeda Pharmaceutical | 0.81 | ||||
3KY | HANSOH PHARMAC | 0.93 | ||||
GU5 | Guangzhou Baiyunshan | 0.93 | ||||
MRK | Merck | 1.16 | ||||
HPX | Hisamitsu Pharmaceutical | 1.59 | ||||
5EA | Elanco Animal | 1.60 |
Complementary Tools for Guangzhou Stock analysis
When running Guangzhou Baiyunshan's price analysis, check to measure Guangzhou Baiyunshan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guangzhou Baiyunshan is operating at the current time. Most of Guangzhou Baiyunshan's value examination focuses on studying past and present price action to predict the probability of Guangzhou Baiyunshan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guangzhou Baiyunshan's price. Additionally, you may evaluate how the addition of Guangzhou Baiyunshan to your portfolios can decrease your overall portfolio volatility.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |